Top

Abbott’s Q2 results top estimates, medical device sales up 11%

Abbott (NYSE:ABT) today reported second-quarter results that came in ahead of the consensus expectation, with its medical device division posting sales growth of more than 11%, and raised its earnings outlook for the rest of the year.

The Chicago-area healthcare giant posted profits of $733 million, or 41¢ per share, on sales of $7.77 billion for the three months ended June 30, for profit growth of 159.0% on sales growth of 17.0% compared with Q2 2017.

Read More on Mass Device